Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Inventory (2020 - 2021)

Cardiol Therapeutics filings provide 2 years of Inventory readings, the most recent being $14273.9 for Q3 2021.

  • On a quarterly basis, Inventory changed N/A to $14273.9 in Q3 2021 year-over-year; TTM through Sep 2021 was $14273.9, a N/A change, with the full-year FY2020 number at $13782.4, changed N/A from a year prior.
  • Inventory hit $14273.9 in Q3 2021 for Cardiol Therapeutics, down from $14617.5 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $14617.5 in Q2 2021 to a low of $13782.4 in Q4 2020.